MENU
+Compare
AGIO
Stock ticker: NASDAQ
AS OF
Sep 4, 04:59 PM (EDT)
Price
$36.13
Change
-$4.48 (-11.03%)
Capitalization
2.1B

AGIO Agios Pharmaceuticals Forecast, Technical & Fundamental Analysis

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology... Show more

Industry: #Biotechnology
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AGIO with price predictions
Sep 04, 2025

AGIO sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for AGIO moved above the 200-day moving average on August 18, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for AGIO just turned positive on August 21, 2025. Looking at past instances where AGIO's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for AGIO crossed bullishly above the 50-day moving average on August 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AGIO advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 219 cases where AGIO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on September 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AGIO as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

AGIO moved below its 50-day moving average on September 04, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AGIO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AGIO broke above its upper Bollinger Band on September 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.723) is normal, around the industry mean (20.013). P/E Ratio (3.600) is within average values for comparable stocks, (51.928). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.122). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (58.140) is also within normal values, averaging (326.881).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AGIO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AGIO is expected to report earnings to fall 1.04% to -190 cents per share on October 30

Agios Pharmaceuticals AGIO Stock Earnings Reports
Q3'25
Est.
$-1.91
Q2'25
Missed
by $0.12
Q1'25
Beat
by $0.23
Q4'24
Beat
by $0.24
Q3'24
Beat
by $1.00
The last earnings report on July 31 showed earnings per share of -192 cents, missing the estimate of -180 cents. With 3.13M shares outstanding, the current market capitalization sits at 2.10B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GFVUX15.97N/A
N/A
Goldman Sachs Focused Value R6
SIDVX12.88N/A
N/A
Hartford Schroders Intl Multi-Cp Val A
IASSX10.84N/A
N/A
VY® American Century Sm-Mid Cp Val S
TWRCX51.22N/A
N/A
American Century Growth C
BAFSX44.46N/A
N/A
Brown Advisory Small-Cap Growth Inst

AGIO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with LGND. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then LGND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
-11.03%
LGND - AGIO
51%
Loosely correlated
+0.72%
ZYME - AGIO
48%
Loosely correlated
-0.42%
CRNX - AGIO
47%
Loosely correlated
-1.15%
SYRE - AGIO
46%
Loosely correlated
+1.07%
OCUL - AGIO
46%
Loosely correlated
-1.85%
More